117 related articles for article (PubMed ID: 30995898)
41. [Study on the cellular proliferation and endocrine activity of the parathyroid gland in hyperparathyroidism].
Hosokawa S
Nihon Hinyokika Gakkai Zasshi; 1993 Aug; 84(8):1424-31. PubMed ID: 8411803
[TBL] [Abstract][Full Text] [Related]
42. Can we predict expected adenoma weight preoperatively with reference to the correlation of preoperative biochemical tests with parathyroid adenoma weight?
Leong DCW; Lo J; Nguyen H; Ryan S
Asian J Surg; 2020 Jul; 43(7):759-764. PubMed ID: 31699571
[TBL] [Abstract][Full Text] [Related]
43. Familial cystic parathyroid adenomatosis.
Mallette LE; Malini S; Rappaport MP; Kirkland JL
Ann Intern Med; 1987 Jul; 107(1):54-60. PubMed ID: 3592449
[TBL] [Abstract][Full Text] [Related]
44. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
45. Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas.
Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
Cancer Genet Cytogenet; 2002 Apr; 134(1):13-7. PubMed ID: 11996789
[TBL] [Abstract][Full Text] [Related]
46. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
47. MIB-1 proliferative index in parathyroid adenoma & hyperplasia.
Karak AK; Sarkar C; Chumber S; Tandon N
Indian J Med Res; 1997 May; 105():235-8. PubMed ID: 9183080
[TBL] [Abstract][Full Text] [Related]
48. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
49. Intracellular lipid droplets in functioning transitional parathyroid oxyphil adenomas. A caveat.
Alpern HD; Roth SI; Olson JE
Arch Surg; 1990 Mar; 125(3):410-1. PubMed ID: 1689566
[TBL] [Abstract][Full Text] [Related]
50. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
51. Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas.
Chikatsu N; Fukumoto S; Takeuchi Y; Suzawa M; Obara T; Matsumoto T; Fujita T
J Biol Chem; 2000 Mar; 275(11):7553-7. PubMed ID: 10713061
[TBL] [Abstract][Full Text] [Related]
52. GCM2 Silencing in Parathyroid Adenoma Is Associated With Promoter Hypermethylation and Gain of Methylation on Histone 3.
Singh P; Bhadada SK; Dahiya D; Saikia UN; Arya AK; Sachdeva N; Kaur J; Behera A; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2021 Sep; 106(10):e4084-e4096. PubMed ID: 34077544
[TBL] [Abstract][Full Text] [Related]
53. Nuclear area measurements of parathyroid adenoma, parathyroid hyperplasia and thyroid follicular adenoma. A comparison.
Tsai TH; Chang TC; Chiang CP
Anal Quant Cytol Histol; 1997 Feb; 19(1):45-8. PubMed ID: 9051185
[TBL] [Abstract][Full Text] [Related]
54. Expression of cellular retinol- and retinoic acid-binding proteins in normal and pathologic human parathyroid glands.
Melhus H; Li Q; Nordlinder H; Farnebo LO; Grimelius L
Endocr Pathol; 2001; 12(4):423-7. PubMed ID: 11914476
[TBL] [Abstract][Full Text] [Related]
55. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
56. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification.
Kaczmarek E; Lacka K; Majewski P; Trzeciak P; Gorna A; Jarmolowska-Jurczyszyn D; Kluk A
J Mol Histol; 2008 Oct; 39(5):509-17. PubMed ID: 18726191
[TBL] [Abstract][Full Text] [Related]
57. Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells.
Juhlin C; Rastad J; Klareskog L; Grimelius L; Akerström G
Am J Pathol; 1989 Aug; 135(2):321-8. PubMed ID: 2782376
[TBL] [Abstract][Full Text] [Related]
58. Intrathyroidal parathyroid adenoma or hyperplasia. An occasionally overlooked cause of surgical failure in primary hyperparathyroidism.
Spiegel AM; Marx SJ; Doppman JL; Beazley RM; Ketcham AS; Kasten B; Aurbach GD
JAMA; 1975 Dec; 234(10):1029-33. PubMed ID: 1242409
[TBL] [Abstract][Full Text] [Related]
59. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas.
Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
Am J Pathol; 2001 Apr; 158(4):1355-62. PubMed ID: 11290553
[TBL] [Abstract][Full Text] [Related]
60. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas.
Arnold A; Staunton CE; Kim HG; Gaz RD; Kronenberg HM
N Engl J Med; 1988 Mar; 318(11):658-62. PubMed ID: 3344017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
